Replies to post #34783 on Inovio Pharmaceuticals Inc (INO)

[Troytex]

Why Ino may be undervalued...recently M.Fool posted update about Ino. device..I have used this technology and seen it work on hundred of people so I am mystified why Ino has not gotten approval..see post below:
Take the case of Novocure (NASDAQ:NVCR), which engineered a device called Optune that applies a gentle electric field to the tumor site in patients with glioblastoma. In 2015, the device quickly advanced to approval for this indication after improving the survival rate of patients

source...recent Motley Fool post///From Troytex in
texas